KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Gains from Investment Securities (2017 - 2025)

Johnson & Johnson's Gains from Investment Securities history spans 17 years, with the latest figure at $63.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 12.5% year-over-year to $63.0 million; the TTM value through Dec 2025 reached $162.0 million, down 6.9%, while the annual FY2025 figure was $162.0 million, 6.9% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $63.0 million at Johnson & Johnson, up from $33.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.7 billion in Q1 2021 and bottomed at -$185.0 million in Q1 2023.
  • The 5-year median for Gains from Investment Securities is $34.5 million (2025), against an average of $126.7 million.
  • The largest annual shift saw Gains from Investment Securities skyrocketed 2218.06% in 2021 before it tumbled 85.59% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $16.0 million in 2021, then surged by 268.75% to $59.0 million in 2022, then crashed by 276.27% to -$104.0 million in 2023, then soared by 169.23% to $72.0 million in 2024, then fell by 12.5% to $63.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Gains from Investment Securities are $63.0 million (Q4 2025), $33.0 million (Q3 2025), and $36.0 million (Q2 2025).